182 related articles for article (PubMed ID: 37461971)
1. P053 Interstitial Nephritis from IBD: Complicated Conclusions.
Kepley A; Marino D; DeCross A
Am J Gastroenterol; 2021 Dec; 116(Suppl 1):S14. PubMed ID: 37461971
[TBL] [Abstract][Full Text] [Related]
2. [Tubulo-interstitial nephritis in inflammatory bowel disease: extra-intestinal manifestation or drug toxicity?].
Heidt J; Ooms EC; van der Werf SD; Groeneveld JH
Ned Tijdschr Geneeskd; 2010; 154():A1647. PubMed ID: 20699041
[TBL] [Abstract][Full Text] [Related]
3. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
4. Adalimumab for maintenance of remission in Crohn's disease.
Townsend CM; Nguyen TM; Cepek J; Abbass M; Parker CE; MacDonald JK; Khanna R; Jairath V; Feagan BG
Cochrane Database Syst Rev; 2020 May; 5(5):CD012877. PubMed ID: 32413933
[TBL] [Abstract][Full Text] [Related]
5. Azithromycin-Induced, Biopsy-Proven Acute Interstitial Nephritis in an Adult Successfully Treated with Low-Dose Corticosteroids.
Woodruff AE; Meaney CJ; Hansen EA; Prescott GM
Pharmacotherapy; 2015 Nov; 35(11):e169-74. PubMed ID: 26598102
[TBL] [Abstract][Full Text] [Related]
6. Acute tubulointerstitial nephritis possibly caused by vedolizumab for ulcerative colitis in a kidney transplant recipient: A case report.
Ogata M; Yazawa M; Terashita M; Osako K; Shirai S
Clin Nephrol; 2023 Aug; 100(2):88-94. PubMed ID: 37288829
[TBL] [Abstract][Full Text] [Related]
7. The histopathologic spectrum of kidney biopsies in patients with inflammatory bowel disease.
Ambruzs JM; Walker PD; Larsen CP
Clin J Am Soc Nephrol; 2014 Feb; 9(2):265-70. PubMed ID: 24262508
[TBL] [Abstract][Full Text] [Related]
8. Medical therapy of inflammatory bowel disease for the 21st century.
Robinson M
Eur J Surg Suppl; 1998; (582):90-8. PubMed ID: 10029372
[TBL] [Abstract][Full Text] [Related]
9. Translating Results from VARSITY to Real World: Adalimumab vs Vedolizumab as First-line Biological in Moderate to Severe IBD.
Moens A; Verstockt B; Alsoud D; Sabino J; Ferrante M; Vermeire S
Inflamm Bowel Dis; 2022 Aug; 28(8):1135-1142. PubMed ID: 34751766
[TBL] [Abstract][Full Text] [Related]
10. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
Gordon M; Taylor K; Akobeng AK; Thomas AG
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD010233. PubMed ID: 25081347
[TBL] [Abstract][Full Text] [Related]
11. Vedolizumab-induced acute interstitial nephritis with failure of steroid prophylaxis on vedolizumab rechallenge.
O'Leary C; Wong D; Wilson G
BMJ Case Rep; 2023 Sep; 16(9):. PubMed ID: 37699736
[TBL] [Abstract][Full Text] [Related]
12. 5-ASA induced interstitial nephritis in patients with inflammatory bowel disease: a systematic review.
Moss JG; Parry CM; Holt RCL; McWilliam SJ
Eur J Med Res; 2022 Apr; 27(1):61. PubMed ID: 35488310
[TBL] [Abstract][Full Text] [Related]
13. Tubulointerstitial nephritis: a biopsy case series of 139 Japanese patients.
Nakaosa N; Tsuboi N; Okabayashi Y; Haruhara K; Sasaki T; Tanno Y; Hirano K; Ikeda M; Miyazaki Y; Shimizu A; Yokoo T
Clin Exp Nephrol; 2022 May; 26(5):435-444. PubMed ID: 35132512
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of Biologic Therapies (Ustekinumab and Vedolizumab) in the Treatment of Inflammatory Bowel Disease (IBD): A Systematic Review.
Ashraf H; Bodapati A; Hanif A; Okafor DK; Katyal G; Kaur G; Khan S
Cureus; 2023 Nov; 15(11):e48338. PubMed ID: 38060699
[TBL] [Abstract][Full Text] [Related]
15. Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease.
Gjuladin-Hellon T; Gordon M; Iheozor-Ejiofor Z; Akobeng AK
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD008414. PubMed ID: 31220875
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive review and update on Crohn's disease.
Gajendran M; Loganathan P; Catinella AP; Hashash JG
Dis Mon; 2018 Feb; 64(2):20-57. PubMed ID: 28826742
[TBL] [Abstract][Full Text] [Related]
17. [Vedolizumab in patients with inflammatory bowel diseases of in real clinical practice].
Shapina MV; Nanaeva BA
Ter Arkh; 2020 Apr; 92(2):67-73. PubMed ID: 32598721
[TBL] [Abstract][Full Text] [Related]
18. Acute interstitial nephritis in patients with inflammatory bowel disease treated with vedolizumab: a systematic review.
Forss A; Flis P; Sotoodeh A; Kapraali M; Rosenborg S
Scand J Gastroenterol; 2024 Apr; ():1-9. PubMed ID: 38682791
[TBL] [Abstract][Full Text] [Related]
19. Renal lithiasis and inflammatory bowel diseases, an update on pediatric population.
Bianchi L; Gaiani F; Bizzarri B; Minelli R; Cortegoso Valdivia P; Leandro G; Di Mario F; De' Angelis GL; Ruberto C
Acta Biomed; 2018 Dec; 89(9-S):76-80. PubMed ID: 30561398
[TBL] [Abstract][Full Text] [Related]
20. Acute kidney injury in a girl with ulcerative colitis and cytomegalovirus-induced focal segmental glomerular sclerosis.
Chirumamilla SR; He C; Racusen LC; Scheimann AO; Cuffari C
World J Pediatr; 2013 Feb; 9(1):84-6. PubMed ID: 21874614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
